Abstract:OBJECTIVE:To investigate the clinical and pathologic characteristics, diagnosis, treatment, prognosis and survival of prostatic stromal tumor of uncertain malignant potential.METHODS:Overall 14 patients with prostatic stromal tumor of uncertain malignant potential were treated from October 2008 to April 2020, the patient age ranged from 27 to 78 years (mean 54 years). The disease duration was 1 to 180 months (mean duration of 46 months). The clinical manifestations mainly included urinary obstructive symptoms and urethral irritating symptoms. The tumors were located in the peripheral zone or the transition zone. Digital rectum examination indicated prostatic tumor. Serum prostatic specific antigen level was always normal or elevated. Transrectal ultrasonography and magnetic resonance imaging indicated prostatic tumor. Magnetic resonance imaging in showed large, round, well-defined masses, which were diffusely heterogeneous signal on T2 weighted imaging. Following the administration of intravenous contrast medium, the lesion had diffuse and heterogeneous enhancement.RESULTS:In the study, 3 cases underwent prostate biopsy, 2 cases underwent transurethral resection of the prostate, 9 cases underwent radical excision or transurethral resection of the prostate with definite diagnosis of pathologic features. Under the light microscope, the interstitial cells of stromal tumor of uncertain malignant potential were overgrowth and fusiform cells showed some degree of pleomorphism, nuclei with few mitotic figures, and necrosis was not often seen. Immunohistochemical staining showed that prostate specific antigen was negative, while vimentin was positive in the tumor tissue, CD34, progesterone receptor and smooth muscle actin were positive in the majority, and Ki67 positive index was 1%-20% (mean 6%). Twelve cases were followed-up, and the time of survival varied from 10 to 96 months (mean 65 months), two cases were lost to the follow-up, one case died of disease at the end of 10 months, nine cases were free of disease recurrence after surgery, two cases underwent more transurethral resection of the prostate due to local recurrence.CONCLUSION:STUMP is a very rare tumor of the specialized prostatic stroma with an unpredictable clinical behavior. The clinical manifestations, transrectal ultrasonography and magnetic resonance imaging are valuable for the diagnosis of prostatic stromal tumor of uncertain malignant potential. Its definite diagnosis depends on pathological examination. Up to now, early surgery and combined therapy are effective treatments for prostatic stromal tumor of uncertain malignant potential.

Magnetic resonance imaging features of prostatic stromal tumour of uncertain malignant potential

Prostatic stromal tumor of uncertain malignant potential: a case report and literature review

Clinical And Pathological Features Of Prostatic Stromal Tumor Of Uncertain Malignant Potential: A Retrospective Study Of 23 Chinese Cases

[A Clinical Analysis of 14 Cases of Prostatic Stromal Tumor of Uncertain Malignant Potential].

Imaging characteristics of uterine smooth muscle tumors of uncertain malignant potential: a case report and literature review

Real-time precision targeted prostate biopsy using transrectal ultrasound-magnetic resonance fusion

Smooth Muscle Tumor of Uncertain Malignant Potential (STUMP): A Systematic Review of the Literature in the Last 20 Years

Clinical And Reproductive Outcomes Of Uterine Smooth Muscle Tumor Of Uncertain Malignant Potential: A Single-Center Retrospective Study

Clinicopathological Features to Distinguish Malignant Solitary Fibrous Tumors of the Prostate from Prostatic Stromal Tumors.

Uterine Smooth Muscle Tumors of Uncertain Malignant Potential (STUMP): A Retrospective Study in a Single Center

Tumor suspicion on MRI incorporating T 2 and Diffusion-weighted imaging predicts adverse pathology on radical prostatectomy

AB188. Single Center Experience of Diagnosis, Treatment and Prognosis of Specialized Stromal Tumors of the Prostate

Correlation of MR perfusion-weighted imaging of prostatic cancer with tumor angiogenesis

Uterine smooth muscle tumors of uncertain malignant potential: a 13-year retrospective study

Oncologic and Reproductive Outcomes of Uterine Smooth Muscle Tumor of Uncertain Malignant Potential: A Single Center Retrospective Study of 67 Cases

MRI characteristics predict risk of pathological upgrade in patients with ISUP grade group 1 prostate cancer

Differential diagnosis of uncommon prostate diseases: combining mpMRI and clinical information

Magnetic resonance imaging radiomics-based prediction of clinically significant prostate cancer in equivocal PI-RADS 3 lesions in the transitional zone

408 A Retrospective Study of Uterine Smooth Muscle Tumor of Uncertain Malignant Potential (ustump): an Analysis of 19 Cases

Single-cell Spatial Proteomic Revelations on the Multiparametric MRI Heterogeneity of Clinically Significant Prostate Cancer

Magnetic Resonance Imaging-Directed Biopsy Improves The Prediction Of Prostate Cancer Aggressiveness Compared With A 12-Core Transrectal Ultrasound-Guided Prostate Biopsy